Alternatives to Drug Discovery AI

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI platform for accelerating novel peptide therapeutic discovery and development.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

AI-powered drug discovery and development platform for biologics.

AI-driven drug discovery platform for rapid development of novel therapeutics.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Selitectix develops AI-powered solutions for drug discovery, focusing on accelerating the identification and optimization of novel therapeutic candidates.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Zyvorx is a biotechnology company using AI and computational biology to accelerate drug discovery and development.

Oncometra is developing an AI-powered platform to accelerate drug discovery and development for oncology.

AI-driven platform for accelerating the discovery and design of novel toxins and therapeutic molecules.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

Vivodyne is developing advanced AI models for drug discovery and development.

AI-first drug design and development company using advanced AI models to discover and develop new medicines.

AI-powered platform for antibody discovery and development to create new medicines.

AI-powered molecular simulation for accelerating drug discovery and materials science.

AI platform for drug discovery and development, accelerating research and clinical trials.

AI-powered drug discovery platform for accelerated molecular design.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

AI-powered research assistant for scientific literature review and data extraction.

AI-powered platform for designing novel molecular structures for new medicines.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Pharmacore is developing a novel AI-powered platform for drug discovery and development.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Developing oral small molecule medicines for immunological and chronic diseases.

Compressing biology to develop the next generation of therapies.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Platform to accelerate scientific discovery using AI.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Computational biology company revolutionizing life sciences product discovery and development using predictive biology.

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

AI-enabled technology for cell biology research and biopharma development.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

AI-powered platform for accelerating drug discovery and personalized medicine development.

Buy research-grade peptides in the UAE & GCC — BPC-157, TB-500, GHK-Cu, NAD+, Semax, Retatrutide & more. HPLC-tested, COA on request, cold-chain delivery. Research use only.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.

Biotech company focused on designing and developing novel biological solutions.

Accelerating medicine for the people who need it, prescribe it, and create it.

Revita Labs is developing a platform to accelerate drug discovery and development using AI.